Risici ved brug af selektive serotoningenoptagelseshæmmere til gravide

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Standard

Risici ved brug af selektive serotoningenoptagelseshæmmere til gravide. / Martens, Terje; Damkier, Per; Videbech, Poul.

I: Ugeskrift for Laeger, Bind 181, Nr. 49, V06190338, 2019.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Harvard

Martens, T, Damkier, P & Videbech, P 2019, 'Risici ved brug af selektive serotoningenoptagelseshæmmere til gravide', Ugeskrift for Laeger, bind 181, nr. 49, V06190338. <https://ugeskriftet.dk/videnskab/risici-ved-brug-af-selektive-serotoningenoptagelseshaemmere-til-gravide>

APA

Martens, T., Damkier, P., & Videbech, P. (2019). Risici ved brug af selektive serotoningenoptagelseshæmmere til gravide. Ugeskrift for Laeger, 181(49), [V06190338]. https://ugeskriftet.dk/videnskab/risici-ved-brug-af-selektive-serotoningenoptagelseshaemmere-til-gravide

Vancouver

Martens T, Damkier P, Videbech P. Risici ved brug af selektive serotoningenoptagelseshæmmere til gravide. Ugeskrift for Laeger. 2019;181(49). V06190338.

Author

Martens, Terje ; Damkier, Per ; Videbech, Poul. / Risici ved brug af selektive serotoningenoptagelseshæmmere til gravide. I: Ugeskrift for Laeger. 2019 ; Bind 181, Nr. 49.

Bibtex

@article{8115ecf5e59346308dd587d138b3c9a8,
title = "Risici ved brug af selektive serotoningenoptagelsesh{\ae}mmere til gravide",
abstract = "Depression in pregnancy is common and may have serious consequences for the mother and foetus when untreated. In this review, we discuss selective serotonin reuptake inhibitor (SSRI) intake in pregnancy, which has been associated with increased risk of several unwanted events. However, the evidence indicating a causal relationship between the intake of SSRI in pregnancy and most investigated outcomes is of very low certainty. Confounding by indication likely accounts for most of the observed correlations. If, for any outcomes, an increased risk exists, the number needed to harm is high, and the clinical significance is unclear.",
author = "Terje Martens and Per Damkier and Poul Videbech",
year = "2019",
language = "Dansk",
volume = "181",
journal = "Ugeskrift for Laeger",
issn = "0041-5782",
publisher = "Almindelige Danske Laegeforening",
number = "49",

}

RIS

TY - JOUR

T1 - Risici ved brug af selektive serotoningenoptagelseshæmmere til gravide

AU - Martens, Terje

AU - Damkier, Per

AU - Videbech, Poul

PY - 2019

Y1 - 2019

N2 - Depression in pregnancy is common and may have serious consequences for the mother and foetus when untreated. In this review, we discuss selective serotonin reuptake inhibitor (SSRI) intake in pregnancy, which has been associated with increased risk of several unwanted events. However, the evidence indicating a causal relationship between the intake of SSRI in pregnancy and most investigated outcomes is of very low certainty. Confounding by indication likely accounts for most of the observed correlations. If, for any outcomes, an increased risk exists, the number needed to harm is high, and the clinical significance is unclear.

AB - Depression in pregnancy is common and may have serious consequences for the mother and foetus when untreated. In this review, we discuss selective serotonin reuptake inhibitor (SSRI) intake in pregnancy, which has been associated with increased risk of several unwanted events. However, the evidence indicating a causal relationship between the intake of SSRI in pregnancy and most investigated outcomes is of very low certainty. Confounding by indication likely accounts for most of the observed correlations. If, for any outcomes, an increased risk exists, the number needed to harm is high, and the clinical significance is unclear.

M3 - Tidsskriftartikel

C2 - 31791474

VL - 181

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

SN - 0041-5782

IS - 49

M1 - V06190338

ER -

ID: 238526051